Authors | RMD Open | A leading rheumatology journal from …
WEBRMD Open is an open access journal and levies an Article Processing Charge (APC) of 2,163 GBP (exclusive of VAT for UK and EU authors). The APC for Letters is 1,082 GBP. There are no submission, colour or page charges. There is a 25% discount for articles where the corresponding author has reviewed for RMD Open within the previous 12 months. A 50% discount on the standard APC will apply to ...
Homepage | RMD Open | A leading rheumatology journal from …
WEBRMD Open. RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies ...
WEBTalor PC et al. RMD Open 2217:e1959 doi:11136rmdopen2211959 1 REVIEW Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis—going beyond treat to target
WEBObjectives: Patient Global Rating of Change (GRC) scales are commonly used in routine clinical care given their ease of use, availability and short completion time. This analysis aimed at assessing the validity of Patient Global Impression of Change (PGIC), a GRC scale commonly used in fibromyalgia, in a Canadian real-life setting.
Reactive arthritis after SARS-CoV-2 infection - RMD Open
WEBSARS-CoV-2 has been recognised as a potential trigger of inflammatory arthritis in individuals with inflammatory rheumatic diseases as well as in previously unaffected individuals. However, new-onset arthritis after COVID-19 is a heterogeneous phenomenon that complicates differential diagnosis. For example, acute arthritis with features of viral arthritis has been reported after COVID-19, as ...
WEBChatidionysiou Sais PP. RMD open 215:e3 doi:11136rmdopen-21-3 1 Viewpoint Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point
Health technology assessment: a framework - RMD Open
WEBIn a time where there is growing pressure on healthcare budgets, there is increased scrutiny of new health technologies, their effectiveness, safety and costs.1 It is in this context that Health Technology Assessment (HTA) has become increasingly important. The purpose of HTA is to provide policymakers with evidence to inform decision-making and develop guidance on the reimbursement and ...
Efficacy and safety of intra-articular therapies in rheumatic and ...
WEBObjective To summarise the evidence on intra-articular therapies (IAT) to inform the 2020 EULAR recommendations. Methods An overview of systematic reviews (SR) including randomised-controlled trials (RCTs) of IAT in adults with arthropathies was performed up to July 2020. Pain, function, and frequency of adverse events were the main efficacy and safety outcomes, respectively.
Active discopathy: a clinical reality - RMD Open
WEBIn the late 1980s, the description by Modic and colleagues of elementary discovertebral changes detected on MRI (Modic classification) suggested for the first time a possible correlation between anatomical and clinical features in a subgroup of patients with non-specific chronic low back pain. Degenerative disc disease is frequent and usually asymptomatic, but Modic 1 changes in the vertebral ...
WEBINTRODUCTION. Immunoglobulin G4-related disease (IgG4-RD) is an increasingly recognised immune- mediated chronic relapsing– remitting inflam-matory condition, characterised by tissue infil-tration with lymphocytes and IgG4-secreting plasma cells, fibrosis and a usually favour-able response to steroids.